Diffusely Increased 18F-FDG Uptake in the Thyroid Gland and Risk of Thyroid Dysfunction: A Cohort Study

Abstract

The impact of incidentally identified diffuse thyroid FDG uptake on 18F-FDG PET/CT scan on the incidence of thyroid dysfunction remains unclear. We examined the association of diffuse thyroid FDG uptake with the development of thyroid dysfunction. This cohort study involved 39,098 Korean adults who were free of malignancy and thyroid disease at baseline and underwent regular health checkup examinations including an 18F-FDG whole body PET/CT scan, thyroid-stimulating hormone and free thyroxine. The participants were annually or biennially followed for up to 5 years. A parametric proportional hazard model was used to estimate the adjusted hazard ratio (HR) and 95% confidence interval (CI). Diffuse thyroid uptake was positively associated with increased risk of thyroid dysfunction in both the cross-sectional and cohort studies. During 104,261.4 person-years of follow-up, 102 incident hypothyroidism cases and 172 hyperthyroidism cases were identified. Multivariable-adjusted HR (95% CI) for incident hypothyroidism or hyperthyroidism comparing diffuse thyroid uptake to no uptake were 15.72 (9.23–26.77) and 7.38 (4.23–12.87), respectively. In this large cohort, incidentally, identified diffuse thyroid uptake on 18F-FDG PET/CT was associated with increased risk of both prevalent and incident thyroid dysfunction. Therefore, baseline and follow-up evaluations in individuals with diffuse thyroid uptake may help identify individuals with thyroid dysfunction.

Early post-treatment 18F-FDG PET/CT for predicting radiation-induced hypothyroidism in head and neck cancer

“…On 18 F-FDG PET/CT scans, normal thyroids usually show low amounts of homogenously distributed radioactivity, with uptake less than or approximately equal to that of the blood pool (visual grade 1–2) [ 20 ]. Focal 18 F-FDG -avid thyroid lesions are potentially malignant, whereas lesions with diffusely increased thyroid 18 F-FDG uptake are associated with thyroid disorders, such as thyroiditis or hypothyroidism [ 21 ]. 18 F-FDG uptake has been shown to correlate with the development of hypothyroidism in patients treated with immunotherapy agents [ 11 , 12 ]; thyroid dysfunction due to immune-mediated damage is the most common immune-related endocrinological adverse event, with a reported incidence of 7–21% [ 22 , 23 ].…”

Incidental thyroid uptake on PET scanning: epidemiology, clinical significance, and management challenge

“…Moreover, these same authors identified age-associated mortality risk in PTC as dependent on BRAF status [101] . In a study comparing PETdetected papillary thyroid cancers to conventionally detected controls, Beck et al [40] described a higher rate of BRAF mutations in the PET-detected cohort (78% vs. 41%, P = 0.05). In this report, the PET-detected cancers were more commonly found in males (54% vs. 26%, P = 0.003) and higher stages (stage III 24% vs. 12%, stage IV 7% vs. 0%, P = 0.05).…”

Exciting Opportunities in Nuclear Medicine Imaging and Therapy

“…Starting with the potential relationship between malignancy-related bone marrow activation and prognosis [8], the Special Issue then features the value of nuclear imaging in inflammatory conditions such as Sjögren’s syndrome or sarcoidosis [9,10]. The next article addresses strategies to optimize reconstruction methods for dosimetry [11], whereas the last original contribution focuses on the association between diffuse thyroid uptake in 18F-FDG PET and the risk of dysfunction [12].…”